Published in TB and Outbreaks Week, November 11th, 2003
"An important prospect for RNAi technology is its possible application in the treatment of diseases using short interfering RNAs (siRNAs)," noted A. Mohmmed and coauthors at the International Centre for Genetic Engineering and Biotechnology in New Delhi. "However, the effect of siRNAs in adult animals and their potential to treat or prevent diseases are yet to be fully investigated."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week